Torrent Pharmaceuticals Ltd.

Torrent Pharmaceuticals Limited (d/b/a Torrent Pharma) is an Indian multinational pharmaceutical company headquartered in Ahmedabad, Gujarat (Torrent House, Off Ashram Road). It was founded in 1959 by U. N. Mehta as Trinity Laboratories, renamed Torrent Pharmaceuticals, and incorporated as a public limited company in 1972 (CIN L24230GJ1972PLC002126). It is the flagship of the Torrent Group and is listed on the BSE (500420) and NSE (TORNTPHARM); market capitalization was roughly ₹1.86–1.9 trillion in September 2026 per Value Research and Arihant Capital. FY2024-25 revenue was ₹11,516 crore, with over 17,000 employees across 15+ countries per the company's annual report; third-party trackers list 17,700–20,300 employees. Ownership is public, with the Mehta family/promoter group holding control.

Operations. Torrent develops, manufactures, and markets branded and generic pharmaceutical formulations in two segments: Branded Generics (India, Brazil, and select emerging markets) and Generics (US, Europe, and other regulated markets). Therapeutic focus areas include cardiovascular, CNS, gastrointestinal, diabetology, vitamins/minerals/nutrients, anti-infectives, pain management, dermatology, gynecology, and oncology. Consumer and specialty brands include Shelcal, Unienzyme, Tedibar, and Ahaglow, following the Curatio Healthcare acquisition (2022); Unichem's domestic business and a controlling stake in JB Chemicals & Pharmaceuticals have also been acquired. The company operates eight manufacturing sites, a research centre, and a bioequivalence facility, with sales in 50+ countries.

Litigation posture. Torrent is an operating company, not a patent assertion entity. In the tracked data it appears in exactly one case — as a defendant and never as a plaintiff — consistent with a generics manufacturer defending ANDA/Paragraph IV suits brought by originator drug companies. The one tracked matter sits in the District of Delaware, a common venue for Hatch-Waxman litigation.

Notable case. Merck Sharp & Dohme Corp. v. Torrent Pharmaceuticals Ltd. et al., No. 1:19-cv-00320 (D. Del., filed Feb. 13, 2019), an ANDA action naming Torrent Pharma Inc. and Torrent Pharmaceuticals Ltd.; a consent judgment was entered in February 2020. Public dockets indicate Torrent is also a defendant in other Delaware ANDA suits (e.g., Novartis matters) beyond this database's single tracked record. No merits conclusions are drawn here.